Clinical Trials List
2022-05-10 - 2026-06-30
Phase III
Not yet recruiting1
Recruiting5
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
Daiichi Sankyo Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Wu-Chou Su Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- Chian-Wei Chen Division of General Internal Medicine
- Yu-Min Yeh Division of Hematology & Oncology
- Po-Lan Su Division of General Internal Medicine
- Yi-Ting Yen Division of General Surgery
- Jui-Hung Tsai Division of Hematology & Oncology
- 蔡政軒 Division of General Internal Medicine
- Shang-Yin Wu Division of Hematology & Oncology
- Seu-Chun Yang Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蕭慈慧 Division of Thoracic Medicine
- 張毓帆 Division of Ophthalmology
- Heng-Sheng Chao 未分科
- Chi-Lu Chiang Division of Thoracic Medicine
- Chia-I Shen Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- Hsu-ching Huang Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 廖斌志 Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Hematology & Oncology
- 許嘉林 Division of Hematology & Oncology
- 魏以宣 Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
- 蔡子修 Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- Chong-Jen Yu Division of Hematology & Oncology
- 廖唯昱 Division of Hematology & Oncology
- 吳尚俊 Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Hematology & Oncology
- 楊景堯 Division of Hematology & Oncology
- YEN-TING LIN Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Hung Chen Division of Hematology & Oncology
- 枋岳甫 Division of Thoracic Medicine
- 陳宏吉 Division of Ophthalmology
- Chih-Hsi Kuo Division of Hematology & Oncology
- Ping-Chih Hsu Division of Hematology & Oncology
- 邱立忠 Division of Thoracic Medicine
- Chien-Ying Liu Division of Hematology & Oncology
- 黃宗楨 Division of Hematology & Oncology
- Jia-Shiuan Ju Division of Hematology & Oncology
- Cheng-Ta Yang Division of Thoracic Medicine
- 柯皓文 Division of Hematology & Oncology
- 黃繼賢 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YEN-HSIANG HUANG 未分科
- 李柏昕 未分科
- JENG-SEN TSENG 未分科
- KUO-HSUAN HSU 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
36 participants
-
Global
586 participants
